Relatro is a medication aimed at managing clinical spasticity in conditions like spinal cord injury, stroke, and cerebral palsy. It helps alleviate symptoms such as clonus, aiding in functional rehabilitation. By targeting skeletal muscle contractile response, Relatro induces relaxation, offering relief from discomfort associated with spasticity. It should be administered cautiously, especially in patients with hepatic diseases, and its usage in pediatric patients requires careful consideration of long-term safety.
